Published in Oncogene on November 12, 2007
Multitargeted therapy of cancer by green tea polyphenols. Cancer Lett (2008) 2.13
Perspectives for cancer prevention with natural compounds. J Clin Oncol (2009) 1.99
Dietary agents for chemoprevention of prostate cancer. Cancer Lett (2008) 1.72
Specific targeting of Wnt/β-catenin signaling in human melanoma cells by a dietary triterpene lupeol. Carcinogenesis (2010) 1.67
Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate. Cancer Res (2009) 1.40
Green tea polyphenols for prostate cancer chemoprevention: a translational perspective. Phytomedicine (2010) 1.37
Apoptosis by dietary agents for prevention and treatment of prostate cancer. Endocr Relat Cancer (2010) 1.26
Clinical development of novel proteasome inhibitors for cancer treatment. Expert Opin Investig Drugs (2009) 1.22
Review: green tea polyphenols in chemoprevention of prostate cancer: preclinical and clinical studies. Nutr Cancer (2009) 1.22
Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth. J Ovarian Res (2010) 1.22
Chronic inflammation in cancer development. Front Immunol (2012) 1.14
Diet and prostate cancer: mechanisms of action and implications for chemoprevention. Nat Rev Urol (2010) 1.14
Green tea polyphenol epigallocatechin-3-gallate inhibits advanced glycation end product-induced expression of tumor necrosis factor-alpha and matrix metalloproteinase-13 in human chondrocytes. Arthritis Res Ther (2009) 1.13
Apoptosis by dietary agents for prevention and treatment of cancer. Biochem Pharmacol (2008) 1.11
Green tea polyphenol EGCG blunts androgen receptor function in prostate cancer. FASEB J (2010) 1.11
Aptamer-conjugated and doxorubicin-loaded unimolecular micelles for targeted therapy of prostate cancer. Biomaterials (2013) 1.07
Green tea polyphenol epigallocatechin 3-gallate in arthritis: progress and promise. Arthritis Res Ther (2010) 1.07
EGCG, green tea polyphenols and their synthetic analogs and prodrugs for human cancer prevention and treatment. Adv Clin Chem (2011) 1.05
Blood and tissue biomarkers in prostate cancer: state of the art. Urol Clin North Am (2010) 1.02
New insights into the mechanisms of green tea catechins in the chemoprevention of prostate cancer. Nutr Cancer (2011) 0.98
Overview of major classes of plant-derived anticancer drugs. Int J Biomed Sci (2009) 0.96
Oral administration of naturally occurring chitosan-based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft model. Carcinogenesis (2013) 0.95
Cancer and metastasis: prevention and treatment by green tea. Cancer Metastasis Rev (2010) 0.93
Nanochemoprevention: sustained release of bioactive food components for cancer prevention. Nutr Cancer (2010) 0.93
Apoptosis and autophagy induction as mechanism of cancer prevention by naturally occurring dietary agents. Curr Drug Targets (2012) 0.92
Down-regulation of myeloid cell leukemia 1 by epigallocatechin-3-gallate sensitizes rheumatoid arthritis synovial fibroblasts to tumor necrosis factor alpha-induced apoptosis. Arthritis Rheum (2009) 0.91
Phytochemicals as Innovative Therapeutic Tools against Cancer Stem Cells. Int J Mol Sci (2015) 0.91
Nanoformulation of natural products for prevention and therapy of prostate cancer. Cancer Lett (2012) 0.90
Epigallocatechin-3-gallate (EGCG) inhibits the migratory behavior of tumor bronchial epithelial cells. Respir Res (2008) 0.87
Survivin knockdown increased anti-cancer effects of (-)-epigallocatechin-3-gallate in human malignant neuroblastoma SK-N-BE2 and SH-SY5Y cells. Exp Cell Res (2012) 0.86
Nanochemoprevention by bioactive food components: a perspective. Pharm Res (2010) 0.86
Complementary and alternative medicines in prostate cancer: from bench to bedside? Oncologist (2012) 0.85
Anticancer activity of green tea polyphenols in prostate gland. Oxid Med Cell Longev (2012) 0.84
Delphinidin, a dietary antioxidant, induces human epidermal keratinocyte differentiation but not apoptosis: studies in submerged and three-dimensional epidermal equivalent models. Exp Dermatol (2013) 0.81
Recent progress on nutraceutical research in prostate cancer. Cancer Metastasis Rev (2014) 0.80
Safety and chemopreventive effect of Polyphenon E in preventing early and metastatic progression of prostate cancer in TRAMP mice. Cancer Prev Res (Phila) (2014) 0.79
Zyflamend sensitizes tumor cells to TRAIL-induced apoptosis through up-regulation of death receptors and down-regulation of survival proteins: role of ROS-dependent CCAAT/enhancer-binding protein-homologous protein pathway. Antioxid Redox Signal (2011) 0.79
Pro-apoptotic and anti-inflammatory properties of the green tea constituent epigallocatechin gallate increase photodynamic therapy responsiveness. Lasers Surg Med (2011) 0.78
Microfluidic System Based High Throughput Drug Screening System for Curcumin/TRAIL Combinational Chemotherapy in Human Prostate Cancer PC3 Cells. Biomol Ther (Seoul) (2014) 0.78
The diarylheptanoid hirsutenone sensitizes chemoresistant ovarian cancer cells to cisplatin via modulation of apoptosis-inducing factor and X-linked inhibitor of apoptosis. J Biol Chem (2013) 0.78
Embelin prevents LMP1-induced TRAIL resistance via inhibition of XIAP in nasopharyngeal carcinoma cells. Oncol Lett (2016) 0.78
Delphinidin sensitizes prostate cancer cells to TRAIL-induced apoptosis, by inducing DR5 and causing caspase-mediated HDAC3 cleavage. Oncotarget (2015) 0.77
Anthocyanin-rich purple corn extract inhibit diabetes-associated glomerular angiogenesis. PLoS One (2013) 0.77
Metformin enhances TRAIL-induced apoptosis by Mcl-1 degradation via Mule in colorectal cancer cells. Oncotarget (2016) 0.77
Nanoencapsulation of natural triterpenoid celastrol for prostate cancer treatment. Int J Nanomedicine (2015) 0.77
5,7-Dihydroxyflavone Enhances the Apoptosis-Inducing Potential of TRAIL in Human Tumor Cells via Regulation of Apoptosis-Related Proteins. Evid Based Complement Alternat Med (2013) 0.76
Impact of Procyanidins from Different Berries on Caspase 8 Activation in Colon Cancer. Oxid Med Cell Longev (2015) 0.75
The anticancer flavonoid chrysin induces the unfolded protein response in hepatoma cells. J Cell Mol Med (2011) 0.75
Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Apoptosis in Prostate Cancer Cells after Treatment with Xanthohumol-A Natural Compound Present in Humulus lupulus L. Int J Mol Sci (2016) 0.75
Natural Compounds As Modulators of Non-apoptotic Cell Death in Cancer Cells. Curr Genomics (2017) 0.75
Green tea and the risk of prostate cancer: A systematic review and meta-analysis. Medicine (Baltimore) (2017) 0.75
Iranian black tea and cowslip extracts induce tumor necrosis factor-alpha secretion from mouse macrophage cell culture. Iran J Pharm Res (2010) 0.75
Epigallocatechin-3-gallate inhibits migration and invasion of human renal carcinoma cells by downregulating matrix metalloproteinase-2 and matrix metalloproteinase-9. Exp Ther Med (2016) 0.75
3-Hydroxyterphenyllin, a natural fungal metabolite, induces apoptosis and S phase arrest in human ovarian carcinoma cells. Int J Oncol (2017) 0.75
Epigallocatechin-3-gallate enhances ER stress-induced cancer cell apoptosis by directly targeting PARP16 activity. Cell Death Discov (2017) 0.75
Andrographolide induces apoptotic and non-apoptotic death and enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in gastric cancer cells. Oncol Lett (2017) 0.75
MDL-12330A potentiates TRAIL-induced apoptosis in gastric cancer cells through CHOP-mediated DR5 upregulation. Korean J Physiol Pharmacol (2017) 0.75
Normalization strategies for cDNA microarrays. Nucleic Acids Res (2000) 4.61
IMGT, the international ImMunoGeneTics database. Nucleic Acids Res (1999) 3.77
IMGT/HLA database--a sequence database for the human major histocompatibility complex. Tissue Antigens (2000) 3.41
Microtubule minus-end anchorage at centrosomal and non-centrosomal sites: the role of ninein. J Cell Sci (2000) 3.07
Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc Natl Acad Sci U S A (2001) 2.79
IMGT, the international ImMunoGeneTics database. Nucleic Acids Res (1997) 2.43
Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J Natl Cancer Inst (1997) 2.39
Taking precautions with ACE inhibitors. A theoretical risk exists in patients with unilateral renal artery stenosis. BMJ (1998) 2.32
Green tea and skin. Arch Dermatol (2000) 2.29
An insight into patient visual experiences during cataract surgery. Br J Ophthalmol (2010) 2.24
Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma. Prostate (2000) 2.19
Characterization of Plasmodium falciparum sporozoite surface protein 2. Proc Natl Acad Sci U S A (1992) 2.00
Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea. Proc Natl Acad Sci U S A (1999) 1.72
Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor kappaB in cancer cells versus normal cells. Arch Biochem Biophys (2000) 1.63
Fournier's gangrene and its emergency management. Postgrad Med J (2006) 1.56
Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells. Toxicol Appl Pharmacol (2000) 1.55
Polyphenols as cancer chemopreventive agents. J Cell Biochem Suppl (1995) 1.52
Green tea polyphenols and cancer: biologic mechanisms and practical implications. Nutr Rev (1999) 1.51
Protective effects of silymarin against photocarcinogenesis in a mouse skin model. J Natl Cancer Inst (1997) 1.51
Green tea polyphenol (-)-epigallocatechin-3-gallate treatment of human skin inhibits ultraviolet radiation-induced oxidative stress. Carcinogenesis (2001) 1.48
Tea in chemoprevention of cancer. Int J Oncol (1996) 1.47
Genetic variation in low-dose UV-induced suppression of contact hypersensitivity and in the skin photocarcinogenesis response. J Invest Dermatol (1997) 1.47
IMGT, the International ImMunoGeneTics database. Nucleic Acids Res (1998) 1.45
Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells. Clin Cancer Res (2001) 1.43
Salmonella typhi vaccine strain CVD 908 expressing the circumsporozoite protein of Plasmodium falciparum: strain construction and safety and immunogenicity in humans. J Infect Dis (1994) 1.43
Green tea polyphenol (-)-epigallocatechin-3-gallate treatment to mouse skin prevents UVB-induced infiltration of leukocytes, depletion of antigen-presenting cells, and oxidative stress. J Leukoc Biol (2001) 1.41
Specific high-affinity binding of fatty acids to epidermal cytosolic proteins. J Invest Dermatol (1991) 1.38
Endoscopic replacement of PEG. Gastrointest Endosc (1994) 1.38
Green tea polyphenols for prostate cancer chemoprevention: a translational perspective. Phytomedicine (2010) 1.37
Experimental model for cartilage tissue engineering to regenerate the zonal organization of articular cartilage. Osteoarthritis Cartilage (2003) 1.37
Comparative features and outcomes of malaria at a tertiary care hospital in Karachi, Pakistan. Int J Infect Dis (2007) 1.37
Inhibition of UVB-induced oxidative stress-mediated phosphorylation of mitogen-activated protein kinase signaling pathways in cultured human epidermal keratinocytes by green tea polyphenol (-)-epigallocatechin-3-gallate. Toxicol Appl Pharmacol (2001) 1.35
Cutaneous photoprotection from ultraviolet injury by green tea polyphenols. J Am Acad Dermatol (2001) 1.34
Sociocultural aspects of areca nut use. Addict Biol (2002) 1.34
Src kinase potentiates androgen receptor transactivation function and invasion of androgen-independent prostate cancer C4-2 cells. Oncogene (2008) 1.33
LIGM-DB/IMGT: an integrated database of Ig and TcR, part of the immunogenetics database. Ann N Y Acad Sci (1995) 1.31
Preoperative intravenous fluid therapy decreases postoperative nausea and pain in high risk patients. Anesth Analg (2005) 1.29
Photodynamic therapy in dermatology. J Am Acad Dermatol (2000) 1.28
Selective growth-inhibitory, cell-cycle deregulatory and apoptotic response of apigenin in normal versus human prostate carcinoma cells. Biochem Biophys Res Commun (2001) 1.27
Lipoxygenase-5 is overexpressed in prostate adenocarcinoma. Cancer (2001) 1.27
Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea reduces UVB-induced inflammatory responses and infiltration of leukocytes in human skin. Photochem Photobiol (1999) 1.27
Idiopathic hypertrophic pachymeningitis: spectrum of the disease. Neuroradiology (1997) 1.27
Green tea polyphenol EGCG suppresses cigarette smoke condensate-induced NF-kappaB activation in normal human bronchial epithelial cells. Oncogene (2006) 1.27
Streptococcus bovis endocarditis, a silent sign for colonic tumour. Colorectal Dis (2009) 1.26
Ultraviolet-B exposure of human skin induces cytochromes P450 1A1 and 1B1. J Invest Dermatol (2000) 1.24
Chemistry of isocoumarins: synthesis and biological screenings of homalicine and dihydrohomalicine. Nat Prod Res (2005) 1.24
Chemoprevention of prostate carcinogenesis by alpha-difluoromethylornithine in TRAMP mice. Cancer Res (2000) 1.24
Phospholipase activation triggers apoptosis in photosensitized mouse lymphoma cells. Cancer Res (1993) 1.22
Inhibition of tumor promotion in SENCAR mouse skin by ethanol extract of Zingiber officinale rhizome. Cancer Res (1996) 1.22
Prevention of UVB-induced immunosuppression in mice by the green tea polyphenol (-)-epigallocatechin-3-gallate may be associated with alterations in IL-10 and IL-12 production. Carcinogenesis (1999) 1.20
Beta-lactams and beta-lactamase-inhibitors in current- or potential-clinical practice: a comprehensive update. Crit Rev Microbiol (2009) 1.20
Cell cycle dysregulation by green tea polyphenol epigallocatechin-3-gallate. Biochem Biophys Res Commun (2000) 1.19
Apoptosis during photodynamic therapy-induced ablation of RIF-1 tumors in C3H mice: electron microscopic, histopathologic and biochemical evidence. Photochem Photobiol (1993) 1.17
Differential antiproliferative and apoptotic response of sanguinarine for cancer cells versus normal cells. Clin Cancer Res (2000) 1.16
Naturally acquired CD8+ cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein. J Immunol (1992) 1.16
Evolution of imaging for abdominal perforation. Ann R Coll Surg Engl (2010) 1.15
Antimutagenic activity of green tea polyphenols. Mutat Res (1989) 1.14
Tea antioxidants in cancer chemoprevention. J Cell Biochem Suppl (1997) 1.11
Phthalocyanine 4 (Pc 4) photodynamic therapy of human OVCAR-3 tumor xenografts. Photochem Photobiol (1999) 1.10
BKCa channels activating at resting potential without calcium in LNCaP prostate cancer cells. J Membr Biol (2006) 1.10
Enhancement of antioxidant and phase II enzymes by oral feeding of green tea polyphenols in drinking water to SKH-1 hairless mice: possible role in cancer chemoprevention. Cancer Res (1992) 1.09
How specific is the rapid urease test for diagnosing Campylobacter pylori? J Clin Pathol (1989) 1.08
Induction of contact hypersensitivity to dimethylbenz(a)anthracene and benzo(a)pyrene in C3H/HeN mice. Cancer Res (1987) 1.07
A ureteric bud cell line induces nephrogenesis in two steps by two distinct signals. Am J Physiol (1996) 1.06
Photodynamic therapy with the phthalocyanine photosensitizer Pc 4 of SW480 human colon cancer xenografts in athymic mice. Clin Cancer Res (2000) 1.06
Kinetics of UV light-induced cyclobutane pyrimidine dimers in human skin in vivo: an immunohistochemical analysis of both epidermis and dermis. Photochem Photobiol (2000) 1.05
Protection against ultraviolet B radiation-induced photocarcinogenesis in hairless mice by green tea polyphenols. Carcinogenesis (1991) 1.05
Tuberculosis diagnosis and treatment practices of private physicians in Karachi, Pakistan. East Mediterr Health J (2003) 1.05
Aryl hydrocarbon hydroxylase, epoxide hydrolase, and benzo[a]-pyrene metabolism in human epidermis: comparative studies in normal subjects and patients with psoriasis. J Invest Dermatol (1984) 1.05
Cardiovascular manifestations in aluminium phosphide poisoning with special reference to echocardiographic changes. J Assoc Physicians India (1995) 1.05
Prognostic value of placental ultrasound in pregnancies complicated by absent end-diastolic flow velocity in the umbilical arteries. Placenta (2004) 1.05
Metabolic requirements for induction of contact hypersensitivity to immunotoxic polyaromatic hydrocarbons. J Immunol (1995) 1.04
CRB1 mutations may result in retinitis pigmentosa without para-arteriolar RPE preservation. Ophthalmic Genet (2001) 1.03
Carcinogen-specific mutational pattern in the p53 gene in ultraviolet B radiation-induced squamous cell carcinomas of mouse skin. Cancer Res (1992) 1.03
Inhibition of skin tumor promoter-caused induction of epidermal ornithine decarboxylase in SENCAR mice by polyphenolic fraction isolated from green tea and its individual epicatechin derivatives. Cancer Res (1992) 1.03
The synthesis, photophysical and photobiological properties and in vitro structure-activity relationships of a set of silicon phthalocyanine PDT photosensitizers. Photochem Photobiol (1997) 1.01
Tea consumption and cancer. World Rev Nutr Diet (1996) 1.01
Laparoscopic resection for colorectal cancer. Br J Surg (2008) 1.01
Green tea polyphenol treatment to human skin prevents formation of ultraviolet light B-induced pyrimidine dimers in DNA. Clin Cancer Res (2000) 1.00
Prostate cancer chemoprevention by green tea: in vitro and in vivo inhibition of testosterone-mediated induction of ornithine decarboxylase. Cancer Res (1999) 1.00
Involvement of caspase-3 in epigallocatechin-3-gallate-mediated apoptosis of human chondrosarcoma cells. Biochem Biophys Res Commun (2000) 0.99
Protection against ultraviolet-B radiation-induced local and systemic suppression of contact hypersensitivity and edema responses in C3H/HeN mice by green tea polyphenols. Photochem Photobiol (1995) 0.99
Differential role of reactive oxygen intermediates in photofrin-I- and photofrin-II-mediated photoenhancement of lipid peroxidation in epidermal microsomal membranes. J Invest Dermatol (1988) 0.99
In vitro and in vivo inhibition of epidermal growth factor receptor-tyrosine kinase pathway by photodynamic therapy. Oncogene (2001) 0.99
Overexpression of ornithine decarboxylase in prostate cancer and prostatic fluid in humans. Clin Cancer Res (1999) 0.99
Involvement of Bcl-2 and Bax in photodynamic therapy-mediated apoptosis. Antisense Bcl-2 oligonucleotide sensitizes RIF 1 cells to photodynamic therapy apoptosis. J Biol Chem (2001) 0.98
Photodynamic therapy results in induction of WAF1/CIP1/P21 leading to cell cycle arrest and apoptosis. Proc Natl Acad Sci U S A (1998) 0.98
Distribution of persistent organochlorine pesticide residues in Gomti River, India. Bull Environ Contam Toxicol (2005) 0.98
Pro-inflammatory and anti-inflammatory cytokine response in diarrhoea-predominant irritable bowel syndrome patients. Trop Gastroenterol (2013) 0.97
Tyrosinase inhibitory lignans from the methanol extract of the roots of Vitex negundo Linn. and their structure-activity relationship. Phytomedicine (2005) 0.97
Involvement of nitric oxide during phthalocyanine (Pc4) photodynamic therapy-mediated apoptosis. Cancer Res (1998) 0.97
Repellent, larvicidal and pupicidal properties of essential oils and their formulations against the housefly, Musca domestica. Med Vet Entomol (2011) 0.97
Strategy for development of a pre-erythrocytic Plasmodium falciparum DNA vaccine for human use. Vaccine (1997) 0.96
Prostate cancer chemoprevention by green tea. Semin Urol Oncol (1999) 0.96
Spontaneous expulsion of a long standing endobronchial metallic foreign body. Indian J Chest Dis Allied Sci (1979) 0.96
Protection against N-nitrosodiethylamine and benzo[a]pyrene-induced forestomach and lung tumorigenesis in A/J mice by green tea. Carcinogenesis (1993) 0.96
Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance. Int J Infect Dis (2007) 0.95